|
Zhongbao Chemicals Co., Limited.
|
Diazolidinyl Urea[78491-02-08]，Antipyrotic, Humectant, Astringent, Antibacterial, Preservatives
|
Send Inquiry
|
|
ZHEJIANG SHENGXIAO CHEMICALS CO.,LTD.
|
GERMAL
Product Number:SX4012
Product Name: Diazolidinyl Urea, Liposerve DU, Germall Ⅱ)
Cas No：78491-02-8
EINECS No.: 278-928-2
Molecular fomular: C8H14N4O7
Molecular weight: : 278.22
I. Introduction
1. Product name:JM-II preservative
2. Chemical name: imidazolidinyl urea
CTFA designation:Imidazolidinyl Urea
3. Working principle:
4. Physical and chemical properties:
JM-II is off-white running powder with a little formaldehyde odor. pH=6.0-7.0.
5. Performance features:
(1)The killing rate of escherichia coli is 99.99%, staphylococcus aureus is 90%, pseudomonas aeruginosa is 90% and tritirachium album is 99.70% when concentration is 0.3%.
(2)The product is safe, non-toxic and non-irritant according to Shanghai Chemical Toxicity Evaluation Standardization Technical Committee.
6. Quality standard Q/SH021-2014
|
Appearance
|
White running powder, no odor or a little special odor
|
|
Nitrogen content%
|
23.0-25.0
|
|
Residue on ignition%≤
|
3.0
|
|
Drying loss%≤
|
3.0
|
7. Packing: 25kg/bottle (plastic bottle)
8. Storage and time:
Keep in dry, clean and well-ventilated place. Expiry date is two years.
II. Applications
1. Application scopes:
Cosmetics, shampoo, and other products
2. Method of application:
Use concentration: 0.1-0.3%
PH range: 0.3-9.0
Operating temperature:≤100℃
|
Item
|
Human skin irritation test
|
|
Sample
|
JM-II preservative 0.3% concentration
|
|
Objectives
|
20 volunteers, health, without dermatitis and skin disease
|
Results:
Human skin irritation integral value table
|
Subject
|
After removal of the test materials
|
Subject
|
After removal of the test materials
|
|
1h
|
24h
|
48h
|
1h
|
24h
|
48h
|
|
Red
|
Swell
|
Red
|
Swell
|
Red
|
Swell
|
Red
|
Swell
|
Red
|
Swell
|
Red
|
Swell
|
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
17
|
0
|
0
|
0
|
0
|
0
|
0
|
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
18
|
0
|
0
|
0
|
0
|
0
|
0
|
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
19
|
0
|
0
|
0
|
0
|
0
|
0
|
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
20
|
0
|
0
|
0
|
0
|
0
|
0
|
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
21
|
0
|
0
|
0
|
0
|
0
|
0
|
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
22
|
1
|
1
|
0
|
0
|
0
|
0
|
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
23
|
0
|
0
|
0
|
0
|
0
|
0
|
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
24
|
0
|
0
|
0
|
0
|
0
|
0
|
|
9
|
0
|
0
|
0
|
0
|
0
|
0
|
25
|
1
|
1
|
1
|
0
|
0
|
0
|
|
10
|
1
|
1
|
1
|
0
|
0
|
0
|
Sub-total
|
5
|
4
|
2
|
1
|
0
|
0
|
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
Total
|
9
|
3
|
0
|
|
12
|
0
|
0
|
0
|
0
|
0
|
0
|
|
13
|
0
|
0
|
0
|
0
|
0
|
0
|
|
14
|
0
|
0
|
0
|
0
|
0
|
0
|
Mean value
|
0.4
|
0.1
|
0
|
|
15
|
0
|
0
|
0
|
0
|
0
|
0
|
|
16
|
1
|
0
|
0
|
0
|
0
|
0
|
|
Send Inquiry
|
Pharma Sources Insight June 2024: Globalization on the Go
